These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29443173)

  • 41. Cost-effectiveness of early assisted discharge for COPD exacerbations in The Netherlands.
    Goossens LM; Utens CM; Smeenk FW; van Schayck OC; van Vliet M; van Litsenburg W; Braken MW; Rutten-van Mölken MP
    Value Health; 2013 Jun; 16(4):517-28. PubMed ID: 23796285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
    Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R
    Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
    Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
    PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Shifting Trend of Transient Ischemic Attack Admission and Prognosis in Canada.
    Yu AYX; Lindsay MP; Kamal N; Fang J; Coutts SB; Hill MD
    Can J Neurol Sci; 2017 Jul; 44(4):391-396. PubMed ID: 28767030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of pelvic exenteration for locally advanced malignancy.
    Koh CE; Badgery-Parker T; Salkeld G; Young JM; Heriot AG; Solomon MJ
    Br J Surg; 2016 Oct; 103(11):1548-56. PubMed ID: 27559684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Labor costs associated with incontinence in long-term care facilities.
    Shih YC; Hartzema AG; Tolleson-Rinehart S
    Urology; 2003 Sep; 62(3):442-6. PubMed ID: 12946743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.
    Bullano MF; Willey V; Hauch O; Wygant G; Spyropoulos AC; Hoffman L
    J Manag Care Pharm; 2005 Oct; 11(8):663-73. PubMed ID: 16194130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of male circumcision for HIV prevention in a South African setting.
    Kahn JG; Marseille E; Auvert B
    PLoS Med; 2006 Dec; 3(12):e517. PubMed ID: 17194197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
    Harris AH; Gospodarevskaya E; Ritter AJ
    Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral decontamination is cost-saving in the prevention of ventilator-associated pneumonia in intensive care units.
    van Nieuwenhoven CA; Buskens E; Bergmans DC; van Tiel FH; Ramsay G; Bonten MJ
    Crit Care Med; 2004 Jan; 32(1):126-30. PubMed ID: 14707570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia.
    Morrisroe K; Stevens W; Sahhar J; Ngian GS; Ferdowsi N; Hansen D; Patel S; Hill CL; Roddy J; Walker J; Proudman S; Nikpour M
    BMC Pulm Med; 2019 Nov; 19(1):226. PubMed ID: 31775705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian Cohort.
    Ademi Z; Liew D; Hollingsworth B; Steg PG; Bhatt DL; Reid CM;
    Cardiovasc Ther; 2013 Feb; 31(1):45-52. PubMed ID: 21884025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hospital costs of ischemic stroke and TIA in the Netherlands.
    Buisman LR; Tan SS; Nederkoorn PJ; Koudstaal PJ; Redekop WK
    Neurology; 2015 Jun; 84(22):2208-15. PubMed ID: 25934858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
    Sheth K; Borker R; Emmett A; Rickard K; Dorinsky P
    Pharmacoeconomics; 2002; 20(13):909-18. PubMed ID: 12381242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Cost-Effectiveness of a Stroke Unit in Providing Enhanced Patient Outcomes in an Australian Teaching Hospital.
    Zhai S; Gardiner F; Neeman T; Jones B; Gawarikar Y
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2362-2368. PubMed ID: 28623119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Health Care Costs Associated with AKI.
    Collister D; Pannu N; Ye F; James M; Hemmelgarn B; Chui B; Manns B; Klarenbach S;
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1733-1743. PubMed ID: 29051143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne Stroke Incidence Study (NEMESIS).
    Dewey HM; Thrift AG; Mihalopoulos C; Carter R; Macdonell RA; McNeil JJ; Donnan GA
    Stroke; 2003 Oct; 34(10):2502-7. PubMed ID: 12970517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Cost-Effectiveness Analysis Comparing Clinical Decision Rules PECARN, CATCH, and CHALICE With Usual Care for the Management of Pediatric Head Injury.
    Dalziel K; Cheek JA; Fanning L; Borland ML; Phillips N; Kochar A; Dalton S; Furyk J; Neutze J; Dalziel SR; Lyttle MD; Bressan S; Donath S; Molesworth C; Hearps SJC; Oakley E; Babl FE;
    Ann Emerg Med; 2019 May; 73(5):429-439. PubMed ID: 30447947
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.